Oxford Nanopore Technologies Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Oxford Nanopore Technologies Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011101
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., is a biotechnology diagnostic company. It develops technologies for molecular detection and analysis. The company offers a range of nanopores and devices such as MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. The company’s technology has a wide range of potential applications in scientific research, personalized medicine, crop science, security and defense, environmental applications among others. The company works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, England, the UK.

Oxford Nanopore Technologies Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Nanopore Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Oxford Nanopore Technologies Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Oxford Nanopore Raises US$64 Million In Venture Financing 10
Oxford Nanopore Technologies Raises US$50.8 Million In Venture Financing 12
Oxford Nanopore Technologies Raises US$41 Million In Financing Round 13
Partnerships 15
Accelrys Enters Into Co-Development Agreement With Oxford Nanopore 15
Oxford Nanopore Technologies Enters Into Licensing Agreement With Harvard University 16
Equity Offering 17
Oxford Nanopore Technologies Raises USD125.7 Million in Private Placement of Shares 17
Oxford Nanopore Raises USD109 Million in Private Placement of Shares 18
Oxford Nanopore Raises USD59 Million in Private Placement of Shares 19
Acquisition 20
Illumina Completes Sale Of 13.5% Stake In Oxford Nanopore For US$91 Million 20
Oxford Nanopore Technologies Ltd – Key Competitors 21
Oxford Nanopore Technologies Ltd – Key Employees 22
Oxford Nanopore Technologies Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Legal and Regulatory 24
Feb 23, 2016: Illumina Sues Oxford Nanopore for Patent Infringement 24
Product News 25
Nov 02, 2016: PacBio Files ITC Patent Infringement Complaint Against Oxford Nanopore 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Oxford Nanopore Technologies Ltd, Medical Equipment, Key Facts 2
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Nanopore Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Nanopore Technologies Ltd, Deals By Market, 2011 to YTD 2017 8
Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Oxford Nanopore Raises US$64 Million In Venture Financing 10
Oxford Nanopore Technologies Raises US$50.8 Million In Venture Financing 12
Oxford Nanopore Technologies Raises US$41 Million In Financing Round 13
Accelrys Enters Into Co-Development Agreement With Oxford Nanopore 15
Oxford Nanopore Technologies Enters Into Licensing Agreement With Harvard University 16
Oxford Nanopore Technologies Raises USD125.7 Million in Private Placement of Shares 17
Oxford Nanopore Raises USD109 Million in Private Placement of Shares 18
Oxford Nanopore Raises USD59 Million in Private Placement of Shares 19
Illumina Completes Sale Of 13.5% Stake In Oxford Nanopore For US$91 Million 20
Oxford Nanopore Technologies Ltd, Key Competitors 21
Oxford Nanopore Technologies Ltd, Key Employees 22
Oxford Nanopore Technologies Ltd, Other Locations 23

★海外企業調査レポート[Oxford Nanopore Technologies Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kang Stem Biotech Co Ltd (217730):製薬・医療:M&Aディール及び事業提携情報
    Summary Kang Stem Biotech Co Ltd (Kang Stem Biotech) is a biopharmaceutical company that develops stem cell therapeutic products for the treatment of incurable diseases using umbilical cord blood-derived stem cells. The company’s stem cell therapy products include Furestem-AD for treating subacute a …
  • Sandoz Inc:企業のM&A・事業提携・投資動向
    Sandoz Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sandoz Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • AMTEC Corporation:企業の戦略・SWOT・財務情報
    AMTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary AMTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bosideng International Holdings Limited:企業の戦略・SWOT・財務情報
    Bosideng International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bosideng International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Heptares Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Heptares Therapeutics Ltd (Heptares), a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise …
  • Westwater Resources, Inc.:企業の戦略・SWOT・財務情報
    Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • International Drug Development Institute-製薬・医療分野:企業M&A・提携分析
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical and …
  • Pentair plc:企業の戦略・SWOT・財務分析
    Pentair plc - Strategy, SWOT and Corporate Finance Report Summary Pentair plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Fomento de Construcciones y Contratas SA (FCC):企業の財務・戦略的SWOT分析
    Fomento de Construcciones y Contratas SA (FCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Telekom Malaysia Berhad (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Berhad (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Oblong Inc (OBLG):企業の財務・戦略的SWOT分析
    Oblong Inc (OBLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AGR Holdings AS:企業の戦略的SWOT分析
    AGR Holdings AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Yuma Energy Inc (YUMA):石油・ガス:M&Aディール及び事業提携情報
    Summary Yuma Energy Inc (Yuma) is an exploration and production company that offers acquisition, development, and exploration for conventional and unconventional oil and natural gas resources in the Gulf Coast and the Permian Basin of west Texas and California. The company designs and performs its o …
  • Consolidated Edison Company of New York, Inc.:発電所・企業SWOT分析
    Consolidated Edison Company of New York, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • Finley Resources Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Finley Resources Inc (Finley) is an oil and gas company that owns, manages, operates and develops oil and gas properties. The company operates its oil and gas properties in the areas of Permian Basin, South Texas, East Texas, Mississippi, Barnett Shale, San Juan Basin, Alabama, Oklahoma and …
  • First Pacific Company Limited:企業の戦略・SWOT・財務情報
    First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report Summary First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Tivoli A/S:企業の戦略・SWOT・財務分析
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cardiva Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cardiva Medical Inc (Cardiva) designs, develops and commercializes of vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures; and …
  • Electric Power Development Co Ltd (9513):企業の財務・戦略的SWOT分析
    Electric Power Development Co Ltd (9513) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆